Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 15, 2006 - Issue 8
Submit an article Journal homepage
183
Views
12
CrossRef citations to date
0
Altmetric
Review

Toll-like receptor modulation in cardiovascular disease: a target for intervention?

Gábor Földes Semmelweis University, 1st Department of Medicine, Budapest, Hungary. [email protected]; Imperial College Medical School, Department of Clinical Cardiology, National Heart and Lung Institute, London, UK
,
Stephan von Haehling Imperial College Medical School, Department of Clinical Cardiology, National Heart and Lung Institute, London, UK
&
Stefan D Anker Imperial College Medical School, Department of Clinical Cardiology, National Heart and Lung Institute, London, UK; Charité Campus Virchow-Klinikum, Division of Applied Cachexia Research, Department of Cardiology, Berlin, Germany
Pages 857-871 | Published online: 21 Jul 2006

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ioanna Vasileiou, Georgia Kostopanagiotou, Athanasios Katsargyris, Chris Klonaris, Despina Perrea & Stamatios Theocharis. (2010) Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia–reperfusion injury?. Expert Opinion on Therapeutic Targets 14:8, pages 839-853.
Read now
Athanasios Katsargyris, Chris Klonaris, Andreas Alexandrou, Alexander E Giakoustidis, Ioanna Vasileiou & Stamatios Theocharis. (2009) Toll like receptors in liver ischemia reperfusion injury: A novel target for therapeutic modulation?. Expert Opinion on Therapeutic Targets 13:4, pages 427-442.
Read now
Athanasios Katsargyris, Chris Klonaris, Elias Bastounis & Stamatios Theocharis. (2008) Toll-like receptor modulation: A novel therapeutic strategy in cardiovascular disease?. Expert Opinion on Therapeutic Targets 12:11, pages 1329-1346.
Read now
Vladimir Y Toshchakov & Stefanie N Vogel. (2007) Cell-penetrating TIR BB loop decoy peptides. Expert Opinion on Biological Therapy 7:7, pages 1035-1050.
Read now

Articles from other publishers (8)

Agata Bielecka-Dabrowa, Jarosław Fabis, Dimitri P. Mikhailidis, Stephan von Haehling, Amirhossein Sahebkar, Jacek Rysz & Maciej Banach. (2018) Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure. Trends in Pharmacological Sciences 39:4, pages 331-353.
Crossref
Kadri Murat Gurses, Duygu Kocyigit, Muhammed Ulvi Yalcin, Hande Canpinar, Mehmet Ali Oto, Necla Ozer, Lale Tokgozoglu, Dicle Guc & Kudret Aytemir. (2015) Enhanced Platelet Toll-like Receptor 2 and 4 Expression in Acute Coronary Syndrome and Stable Angina Pectoris. The American Journal of Cardiology 116:11, pages 1666-1671.
Crossref
Wolfram Doehner, Stephan von Haehling,Stefan D. Anker. 2011. Heart Failure: A Companion to Braunwald's Heart Disease. Heart Failure: A Companion to Braunwald's Heart Disease 330 345 .
Michael J. Haas & Arshag D. Mooradian. (2010) Therapeutic Interventions to Enhance Apolipoprotein A-I-Mediated Cardioprotection. Drugs 70:7, pages 805-821.
Crossref
Stephan von Haehling, Joerg C. Schefold, Mitja Lainscak, Wolfram Doehner & Stefan D. Anker. (2009) Inflammatory Biomarkers in Heart Failure Revisited: Much More than Innocent Bystanders. Heart Failure Clinics 5:4, pages 549-560.
Crossref
Stephan von Haehling, Mitja Lainscak, Jochen Springer & Stefan D. Anker. (2009) Cardiac cachexia: A systematic overview. Pharmacology & Therapeutics 121:3, pages 227-252.
Crossref
Stephan von Haehling, Joerg C. Schefold, Jochen Springer & Stefan D. Anker. (2008) The Cholesterol Paradox Revisited: Heart Failure, Systemic Inflammation, and Beyond. Heart Failure Clinics 4:2, pages 141-151.
Crossref
Hyun-Ku Lee, Steven J. Brown, Hugh Rosen & Peter S. Tobias. (2007) Application of β-Lactamase Enzyme Complementation to the High-Throughput Screening of Toll-Like Receptor Signaling Inhibitors. Molecular Pharmacology 72:4, pages 868-875.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.